A clinical study of the Dermatology Clinic to investigate the efficacy and safety of L19IL2/L19TNF.
Aim of the study
The clinical study investigates the efficacy and safety of L19IL2/L19TNF after injection into the tumor in patients with local lesions of white skin cancer (subtypes of basal cell carcinoma or squamous cell carcinoma).
Who can take part?
The study includes patients with white skin cancer of the basal cell carcinoma or squamous cell carcinoma subtype. The cancer must not have formed any distant metastases and must not have affected any lymph nodes. You must be between 18 and 100 years old.
Procedure
During the treatment phase of four weeks, the patient receives an injection of L19IL2/L19TNF into the tumor lesion(s) once a week. Two weeks after completion of the treatment, a follow-up examination is performed to evaluate the tumor. Surgery to completely remove the lesion(s) may be performed within 6 weeks of the follow-up visit if deemed necessary by the investigator. The safety and efficacy of the treatment will be evaluated throughout the duration of their participation in the study.